Tenet Healthcare Corporation (THC) Q3 2026 Earnings Call Transcript

Tenet Healthcare Corporation (THC) Q3 2026 Earnings Call Transcript

Seeking Alpha • 6 hours ago

Tenet Reports Strong Third Quarter 2026 Results; Raises 2026 Financial Outlook

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2026. "Our outperformance in the third quarter of 2026 was driven by sustained strength in same-store revenue growth and effective expense management," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Our focus on patient-centered care, support for physician partners, technology-enabled growth and operating initiatives continue to deli.

Business Wire • 14 hours ago

Tenet Healthcare (THC) Surpasses Q3 Earnings and Revenue Estimates

Tenet Healthcare (THC) came out with quarterly earnings of $6.64 per share, beating the Zacks Consensus Estimate of $4.6 per share. This compares to earnings of $3.7 per share a year ago.

Zacks Investment Research • 11 hours ago

Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • 8 hours ago

THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised

Tenet Healthcare's Q3 earnings surge 79.5% on strong hospital performance and cost discipline, prompting higher 2026 EPS and EBITDA guidance.

Zacks Investment Research • 5 hours ago

Here's Why Tenet Healthcare (THC) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Oct 28, 2026

Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?

Can THC deliver a Q3 earnings beat? Ambulatory Care growth and higher revenues per adjusted admission offer support, but hospital volume declines and costs loom.

Zacks Investment Research • Oct 27, 2026

Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Oct 27, 2026

Insights Into Tenet (THC) Q3: Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Investment Research • Oct 27, 2026

Tenet Healthcare (THC) Earnings Expected to Grow: Should You Buy?

Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 22, 2026